Article citationsMore>>

Ferrrero, J., Williams, L., Stella, H., et al. (2016) First-in-Human, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of Aducanumab (BIIB037) in Mild-to-Moderate Alzheimer’s Disease. Alzheimer’s & Dementia, 2, 169-176.
https://doi.org/10.1016/j.trci.2016.06.002

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top